Related Experiment Video
Updated: Oct 29, 2025

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Current Progress in Investigating Mature T- and NK-Cell Lymphoma Gene Aberrations by Next-Generation Sequencing (NGS)
Lifen Zhu1, Shufang Xie1,2, Chen Yang1,3
1Molecular diagnosis laboratory, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, People's Republic of China.
Abstract:
Despite efforts to abrogate the severe threat to life posed by the profound malignancy of mature natural killer/T-cell lymphoma (NKTCL), therapeutic advances still require further investigation of its inherent regulatory biochemical processes. Next-generation sequencing (NGS) is an increasingly developing gene detection technique, which has been widely used in lymphoma genetic research in recent years. Targeted therapy based on the above studies has also generated a series of advances, making genetic mutation a new research hotspot in lymphoma. Advances in NKTCL-related gene mutations are reviewed in this paper.
Insights
Investigating gene mutations in mature natural killer/T-cell lymphoma (NKTCL) is crucial for developing new treatments. This review covers recent advances in NKTCL-related gene mutations and targeted therapies.
Area of Science:
- Oncology
- Hematology
- Genetics
Background:
- Mature natural killer/T-cell lymphoma (NKTCL) poses a severe threat to life.
- Current therapeutic strategies require further investigation into NKTCL's regulatory biochemical processes.
Purpose of the Study:
- To review recent advances in NKTCL-related gene mutations.
- To highlight the role of genetic mutations in NKTCL pathogenesis and targeted therapy.
Main Methods:
- Literature review of studies on NKTCL genetics.
- Focus on next-generation sequencing (NGS) applications in lymphoma research.
- Analysis of gene mutations identified in NKTCL.
Main Results:
- Next-generation sequencing (NGS) is a key technique in lymphoma genetic research.
- Genetic mutations are increasingly recognized as a critical area in lymphoma research.
- Advances in understanding NKTCL-specific gene mutations are emerging.
Conclusions:
- Further research into NKTCL-related gene mutations is essential for therapeutic progress.
- Targeted therapies based on genetic findings show promise for NKTCL treatment.
- Genetic mutation analysis is a vital research hotspot for NKTCL.
More Related Videos
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016